Cynata Therapeutics Receives approval for acute graft-versus-host disease clinical trial
Cynata Therapeutics (CYP) receives approval to launch a phase two clinical trial in acute...
Biotechnology company Cynata Therapeutics (CYP) has received a research and development (R&D) tax incentive refund of over $1.3 million
The R&D tax incentive...
Biotech Cynata Therapeutics has announced positive efficacy data from a Cymerus mesenchymal stem cell study in rodents with IPF
IPF, idiopathic pulmonary fibrosis,...
